Skip to main content
OpenTrials

Clinical trial condition

Advanced Solid Tumor

Explore clinical trials studying Advanced Solid Tumor. Study availability and eligibility vary by location and protocol.

514 public trials 240 recruiting studies
Refine in advanced search Browse all conditions

Advanced Solid Tumor trial results

Active, Not Recruiting

Study of LP-184 in Patients With Advanced Solid Tumors

NCT05933265

Conditions
Advanced Solid Tumor, Breast Diseases, Breast Neoplasms, +15 more
Locations
  • Highlands Oncology Group Springdale, Arkansas, United States
  • Indiana University Melvin and Bren Simon Cancer Center Indianapolis, Indiana, United States
  • Norton Healthcare, Inc. Louisville, Kentucky, United States
  • John Hopkins - The Sidney Kimmel Comprehensive Cancer Center Baltimore, Maryland, United States
View Trial Details
Active, Not Recruiting

A Study of NTX-1088, a Monoclonal Antibody Targeting the Poliovirus Receptor (PVR, CD155), as Monotherapy and Combined With Pembrolizumab

NCT05378425

Conditions
Advanced Solid Tumor, Cancer, Locally Advanced Solid Tumor, +7 more
Locations
  • City of Hope Duarte, California, United States
  • Ochsner Clinic Foundation New Orleans, Louisiana, United States
  • The University of Texas MD Anderson Cancer Center Houston, Texas, United States
  • Hadassah Medical Center Jerusalem, Israel
View Trial Details
Active, Not Recruiting

A Study YL201 in Patients With Selected Advanced Solid Tumors

NCT06057922

Conditions
Advanced Solid Tumor
Locations
  • Anhui Provincial Cancer Hospital Hefei, Anhui, China
  • The First Affiliated Hospital of Anhui Medical University Hefei, Anhui, China
  • The First Affiliated Hospital of USTC Hefei, Anhui, China
  • The Second Hospital of Anhui Medical University Hefei, Anhui, China
View all 52 locations
View Trial Details
Active, Not Recruiting

Study of RP3 Monotherapy and RP3 in Combination With Nivolumab in Patients With Solid Tumours

NCT04735978

Conditions
Advanced Solid Tumor
Locations
  • University of Iowa Iowa City, Iowa, United States
  • UPMC Hillman Cancer Center Pittsburgh, Pennsylvania, United States
  • MD Anderson Cancer Center Houston, Texas, United States
  • Laboratoire de Recherche Translationnelle en Immunotherapie (LRTI), Gustave Roussy Villejuif, France
View all 13 locations
View Trial Details
Active, Not Recruiting

A Study to Investigate Safety and Tolerability of TransCon IL-2 β/γ Alone or in Combination With Pembrolizumab and/or TransCon TLR7/8 Agonist or Other Anticancer Therapies in Adult Participants With Locally Advanced or Metastatic Solid Tumor Malignancies

NCT05081609

Conditions
2L+ Cervical Cancer, Advanced Solid Tumor, Female Urogenital Diseases, +27 more
Locations
  • Ascendis Pharma Investigational Site Los Angeles, California, United States
  • Ascendis Pharma Investigational Site Los Angeles, California, United States
  • Ascendis Pharma Investigational Site Springfield, Illinois, United States
  • Ascendis Pharma Investigational Site Louisville, Kentucky, United States
View all 68 locations
View Trial Details

Related conditions